COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements

COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]

 

AstraZeneca
Press ReleasesNo new digest announcements identified

Bharat Biotech
Press Releases – No new digest announcements identified

BioCubaFarma – Cuba
Últimas Noticias – Website not leading at inquiry

 

Biontech
Press Releases
Statement on Humanitarian Aid in Ukraine
7 March 2022

 

CanSinoBIO
News – [Website not responding at inquiry]

Clover Biopharmaceuticals – China
News – No new digest announcements identified

 

Curevac [Bayer Ag – Germany]
News
CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer®
March 1, 2022
The RNA Printer® is CureVac’s integrated and automated manufacturing solution for RNA vaccines and therapeutics
CureVac RNA Printer GmbH to provide dedicated infrastructure to accelerate development and broaden application range of The RNA Printer®
Dr. Markus Bergmann appointed as General Manager for CureVac RNA Printer GmbH

 

Gamaleya National Center
Latest News and Events – See Russia below and under Ukraine above

IMBCAMS, China
Home – Website not responding at inquiry

 

Janssen/JNJ
Press Releases
Johnson & Johnson Announces Landmark Agreement to Enable its COVID-19 Vaccine to be Manufactured and Made Available by an African Company for People Living in Africa
United States
:: Aspen will manufacture and provide the Johnson & Johnson COVID-19 vaccine under its own brand name per the terms of agreement
:: Ensuring equitable, global access to COVID-19 vaccines has been a pillar of Johnson & Johnson’s response since the earliest days of the pandemic
:: The production of COVID-19 vaccines on multiple continents is critical to supporting an equitable response, controlling the pandemic, and improving long-term health security
NEW BRUNSWICK, NJ (March 8, 2022) – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the completion of a landmark agreement between Janssen Pharmaceuticals, Inc., and manufacturer Aspen SA Operations (Pty) Ltd, based in South Africa, to enable the first COVID-19 vaccine to be manufactured and made available by an African company for people living in Africa, with the goal of increasing COVID-19 vaccination rates across the continent…

 

Moderna
Press Releases
March 10, 2022
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate

March 7, 2022
Moderna Announces Its Global Public Health Strategy
:: Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025
:: Moderna launches mRNA Access, a new collaborative enabling researchers around the world to utilize Moderna’s mRNA technology platform to pursue research in their own labs on emerging and neglected infectious diseases
:: Moderna expands commitment to never enforce COVID-19 patents in the Gavi COVAX AMC for 92 low- and middle-income countries
:: Moderna has entered into a Memorandum of Understanding with the Government of the Republic of Kenya to establish its first mRNA manufacturing facility on the continent of Africa

March 7, 2022
Moderna Announces Memorandum of Understanding with the Government of the Republic of Kenya to Establish its First mRNA Manufacturing Facility in Africa

 

Novavax
Press Releases
Novavax Announces Launch of Global Vaccine Education Programs
Mar 10, 2022

Novavax Statement on Availability of its COVID-19 Vaccine in New Zealand
Mar 08, 2022

 

Pfizer
Recent Press Releases
03.09.2022
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants

 

Sanofi Pasteur
Press Releases – No new digest announcements identified

 

Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified

Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.

 

Sinopharm/WIBPBIBP
News – No new digest announcements identified

 

Sinovac
Press Releases – No new digest announcements identified

 

Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified

Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]

 

::::::

GSK
Press releases for media – No new digest announcements identified

 

Merck
News releases – No new digest announcements identified

 

Novartis
News – No new digest announcements identified

 

SK Biosciences
Press releases – No new digest announcements identified

 

Valneva
Press Releases
March 11, 2022
Valneva Provides Regulatory Update on its COVID-19 Vaccine Candidate

March 8, 2022
Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate